Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Viyash Scientific LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:512529 P/E (TTM) :0
ISIN Demat:INE807F01027 Div & Yield %:0 EPS (TTM) :0.36
Book Value (RS) :27.9296172 Market Cap (Rs Cr.):9043.25 Face Value (RS) :2
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.040.030.020.010.02
Long Term Debt-Equity Ratio0.000.000.000.000.01
Current Ratio1.301.221.671.761.34
Fixed Assets1.961.752.042.032.63
Inventory5.984.093.843.866.88
Debtors3.145.776.743.865.19
Interest Cover Ratio6.571.33-2.8810.7516.25
PBIDTM (%)19.458.750.8412.2419.85
PBITM (%)14.593.45-3.257.8816.41
PBDTM (%)17.236.17-0.2811.5118.84
CPM (%)13.726.681.3711.1115.54
APATM (%)8.861.37-2.736.7412.10
ROCE (%)2.230.52-0.681.654.34
RONW (%)1.420.22-0.581.433.27

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)